A novel combination of an investigational intravesical drug delivery system designed to provide sustained release of gemcitabine into the bladder (Gem-iDRS, Inlexzo) and systemic treatment with the ...

JPMorgan Industrials Conference 2026 March 17, 2026 12:20 PM EDTCompany ParticipantsCristina Gallo-Aquino - CFO, EVP & ...

Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a ...

Q4 2025 Earnings Call March 18, 2026 8:30 AM EDTCompany ParticipantsMarvin Slosman - President, CEO & DirectorMichael Lawless ...

Need a quote from a Motley Fool analyst? Stephen Altemus, and Chief Financial Officer, Peter McGrath, are leading the call ...

Net loss in the fourth quarter of 2025 was $0.3 million or $0.05 per share compared to a net profit of $23,000 in the fourth quarter of 2024. EBITDA was $0.7 million in the fourth quarter of 2025 ...

KORU Medical Systems, Inc. (NASDAQ:KRMD) Q4 2025 Earnings Call Transcript March 12, 2026 KORU Medical Systems, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02.

So, while we expect to continue to grow NOI both organically on a same-store level and incrementally through future ...

Duluth Holdings Inc. (NASDAQ:DLTH) Q4 2025 Earnings Call Transcript March 19, 2026 Duluth Holdings Inc. beats earnings ...

Operator: Good morning, and welcome to the Ocean Power Technologies’ Third Quarter Fiscal 2026 Earnings Conference Call. A ...

Announced a 50-megawatt, 500-engine deal described as its largest yet in the segment. Gross margin -- Achieved a 17% positive ...